Study S003265

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07340320
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: DOUBLE
Status: RECRUITING
Enrollment: 240
Start: 2026-02-06
Primary completion: 2027-04-16
Lead sponsor: Corxel Pharmaceuticals
Conditions: Type II Diabetes Mellitus
Interventions: DRUG:CX11; OTHER:Placebo
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change in Glycosylated hemoglobin, Type A1C (HbA1c) from baseline [At Week 24]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.